During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...
News Medical on MSN1d
Interactive atlas unveils immune changes in multiple myelomaMultiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...
Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...
Although myeloma is treatable, it is generally not curable, and advanced therapies like blood stem cell transplantation can ...
rsvplive on MSN5d
Dearbhla Mescal shares the sweet gesture son Paul made to her doctor after cancer treatmentDearbhla was diagnosed in July 2022 with multiple myeloma, a type of bone marrow cancer that can affect the spine, skull, ...
Stand Up To Cancer® (SU2C) today announced a collaboration with Johnson & Johnson aimed at supporting research testing a ...
News Medical on MSN3d
Stand Up To Cancer partners with Johnson & Johnson to explore new treatment for AL amyloidosisStand Up To Cancer (SU2C) today announced a collaboration with Johnson & Johnson aimed at supporting research testing a combination of two types of targeted therapies, teclistamab and daratumumab, to ...
Johnson & Johnson seeks US & EU approvals for Darzalex Faspro/Darzalex as subcutaneous monotherapy for high-risk smoldering multiple myeloma: Raritan, New Jersey Monday, November ...
UK pharma group posts ‘statistically significant’ trial results for treatment combined with Blenrep pulled in 2022 ...
Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback